Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension

RxCUI
1812945
RxNorm name
Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
Display name
Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
Full name
Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125597VaxchoraCholera Vaccine, Live, Oral351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2d33d9ae-1fe6-477e-9285-8890f6e98be4Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension [PSN] · Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML Oral Suspension [SCD]23These highlights do not include all the information needed to use VAXCHORA safely and effectively. See full prescribing information for VAXCHORA. VAXCHORA ® (Cholera Vaccine, Live, Oral) Suspension for Oral Administration Initial U.S. Approval: 201620250207